DUBLIN--(BUSINESS WIRE)--The "Cell Analysis Instruments Market - Growth, Trends, and Forecasts (2020 - 2025)" report has been added to ResearchAndMarkets.com's offering.
The cell analysis instruments market is found increasing due to the growing burden of cancer across the globe and growing biotech industry and research in cell biology.
Cancer is one of the major causes of deaths across the world, with 609,640 victims in 2018, accounting for nearly one in six deaths. The disease has witnessed significant growth in the last few decades and is expected to rise rapidly over the forecast period. According to the National Cancer Institute, there were around 1,735,350 cases of cancer found in the United States during the year 2018.
In addition, WHO has estimated the cancer deaths to increase by 70% over the next two decades, worldwide. The recent years have observed significant inclination by biotech research companies and universities to invest in various single-cell DNA and RNA quantification techniques. Hence, all these factors are found increasing the demand for cell analysis instruments market.
- Becton Dickinson and Company
- Sartorius AG
- Danaher Corporation
- Merck KGaA
- Thermo Fisher Scientific
- Miltenyi Biotec
- STEMCELL Technologies
- Terumo BCT
- Promega Corporation
- GE Healthcare
Key Market Trends
Cell Counting Application is Expected to Register a High Growth During the Forecast Period
Cell counting is done to compare different cell populations or responses. It is the fundamental and critical to numerous biological experiments. Cell counting is done by various methods such as automated cell counter, cell cycle analysis, counting cells without cell staining. The cell counting is one of the most important steps in biology and medicine. The cell counting used in medicine to understand the concentration of blood cells which can provide crucial information about the health situation of a person. In cell therapy, it is used to control the dose of cells given to the patient.
Similarly, cell counting is also used to know the concentration of bacteria, viruses and other pathogens in the blood or in other bodily fluids can reveal information about the progress of infectious disease and about the degree of success with which the immune system is dealing with the infection. With the wide applications of cell counting, it is expected that this segment will be witnessing a good CAGR over the forecast period. In addition, increasing burden of life-threatening diseases such as cancer is augmenting the growth of market studied.
North America is Expected to Dominate the Cell Analysis Instruments Market
North America is expected to dominate the market due to the increasing incidences of cancer and increasing corporate & government funding in cell-based research. Being the most developed economy and healthcare industry, the United States has put a benchmark for several markets. Due to the presence of major companies and the strong R&D in biotechnology, the country is witnessing rapid growth in the market studied. The focus of the US government is to further strengthen its healthcare industry, thus there has been a significant increase in the research funding.
Along with that, the country has a large number of laboratories which is augmenting the demand for cell analysis instruments, and ultimately, the US holds the largest share of the market owing to the high demand.
Key Topics Covered:
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Cancer Incidence Rate
4.2.2 Growing Biotech Industry and Research in Cell Biology
4.3 Market Restraints
4.3.1 High Cost of Cell Analysis
4.3.2 Complex Regulatory Scenario
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Product
188.8.131.52 Flow Cytometers
184.108.40.206 Cell Microarrays
5.2 By Application
5.2.1 Cell Counting
5.2.2 Cell Viability
5.2.3 Cell Identification
5.2.4 Target Identification
5.3 By End-User
5.3.1 Academic and Research Institutes
5.3.2 Pharmaceutical & Biotechnology Companies
5.4.1 North America
5.4.4 Middle-East and Africa
5.4.5 South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
For more information about this report visit https://www.researchandmarkets.com/r/q1cmpe